This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Personal history of risk-factors, not elsewhere classified
Z21_PERSONAL_HISTORY_RISK__NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
493 |
4. Check minimum number of eventsNone |
493 |
5. Include endpointsNone |
493 |
6. Filter based on genotype QC (FinnGen only) |
493 |
Control definitions (FinnGen only)
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Z[8-9]
Similar endpoints
↥List of similar endpoints to
Personal history of risk-factors, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Persons with potential health hazards related to family and personal history and certain conditions influencing health status
- Factors influencing health status and contact with health services
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 493 | 300 | 193 |
| Unadjusted period prevalence (%) | 0.10 | 0.10 | 0.09 |
| Median age at first event (years) | 38.02 | 31.63 | 47.95 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 439
- Matched controls
- 4391
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Z91.5
ICD-10 Finland
Personal history of self-harm
3666.1
323.0
317
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
46.9
169.8
210
84
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
50.5
159.5
193
67
F32.9
ICD-10 Finland
Depressive episode, unspecified
14.3
120.5
241
344
N05AH04
ATC
quetiapine; oral
13.3
120.1
256
417
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
30.2
81.0
110
48
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
14.6
78.8
142
139
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
12.7
76.7
149
171
N05AH03
ATC
olanzapine; systemic
14.2
74.3
135
133
X44
ICD-10 Finland
Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances
52.4
65.6
78
18
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
33.1
65.3
86
32
N05BA04
ATC
oxazepam; oral
6.3
63.4
220
606
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
10.9
61.3
127
158
N05AX08
ATC
risperidone; systemic
11.1
57.6
117
139
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
33.9
56.7
74
26
N06AX16
ATC
venlafaxine; oral
7.0
56.4
162
337
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
12.4
56.2
107
111
N06AX11
ATC
mirtazapine; oral
5.3
55.4
234
779
N05AA02
ATC
levomepromazine; systemic
14.5
53.0
93
80
N05AX12
ATC
aripiprazole; systemic
13.8
52.4
94
85
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
7.0
51.9
147
295
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
7.6
51.0
134
241
F29
ICD-10 Finland
Unspecified nonorganic psychosis
13.5
50.4
91
83
F32.3
ICD-10 Finland
Severe depressive episode with psychotic symptoms
20.0
50.4
77
46
N07BB01
ATC
disulfiram; oral
13.1
50.1
92
87
Z72.8
ICD-10 Finland
Other problems related to lifestyle
187.4
48.9
50
*
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
11.6
48.1
94
101
N05AF03
ATC
chlorprothixene; systemic
18.7
44.8
70
44
N06AB06
ATC
sertraline; oral
6.4
44.2
132
277
N05BA01
ATC
diazepam; systemic, rectal
6.5
43.9
128
260
N06AB03
ATC
fluoxetine; oral
6.5
43.8
128
261
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
6.1
43.8
136
300
N03AX09
ATC
lamotrigine; oral
9.6
43.1
93
119
N05CD07
ATC
temazepam; oral
7.9
42.4
105
168
F10.20
ICD-10 Finland
Alcohol dependence currently independent
21.7
41.9
62
33
N03AG01
ATC
valproic acid; systemic, rectal
9.1
41.6
93
126
N05CF01
ATC
zopiclone; oral
4.4
41.0
197
690
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
21.3
41.0
61
33
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
16.7
40.6
66
46
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
8.4
40.3
95
140
F60.9
ICD-10 Finland
Personality disorder, unspecified
22.1
39.5
58
30
X78
ICD-10 Finland
Intentional self-harm by sharp object
47.7
39.0
47
11
Z91.1
ICD-10 Finland
Personal history of noncompliance with medical treatment and regimen
+∞
38.1
36
*
N06AB04
ATC
citalopram; systemic
4.6
37.4
159
486
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
31.5
36.4
48
17
F41.2
ICD-10 Finland
Mixed anxiety and depressive disorder
5.7
34.8
112
250
N05AB03
ATC
perphenazine; systemic, rectal
14.3
34.7
60
48
IEY05
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, individual
10.6
33.5
67
73
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
26.9
33.5
46
19
P29
ICPC
Psychological sympt/compl other
6.4
32.3
92
175
Z2446
NOMESCO Finland
Social worker
6.9
32.0
85
147
C07AA05
ATC
propranolol; systemic
4.0
31.2
153
520
F10.21
ICD-10 Finland
Alcohol dependence currently abstinent, but staying in restrictive environment
41.4
30.8
38
10
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.7
30.2
94
199
Z91.0
ICD-10 Finland
Personal history of allergy, other than to drugs and biological substances
323.4
30.2
30
*
X84
ICD-10 Finland
Intentional self-harm by unspecified means
114.7
30.1
32
*
N05AN01
ATC
lithium; oral
13.2
29.8
53
45
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
9.3
29.8
64
79
N03AE01
ATC
clonazepam; systemic
8.4
29.6
68
94
N06AB10
ATC
escitalopram; oral
3.6
29.0
163
614
T50.9
ICD-10 Finland
Poisoning: Other and unspecified drugs, medicaments and biological substances
52.4
28.8
34
7
F61.0
ICD-10 Finland
Mixed personality disorders
17.8
28.7
45
28
ICZ03
NOMESCO Finland
Participation in compiling a psychiatric treatment plan
8.8
28.1
62
80
N05BA06
ATC
lorazepam; systemic, sublingual
9.4
27.8
59
71
ICB01
NOMESCO Finland
Psychiatric treatment plan, standard
9.4
27.8
59
71
ZY000
NOMESCO Finland
Hospital inpatient
20.4
27.5
41
22
F31.6
ICD-10 Finland
Bipolar affective disorder, current episode mixed
20.4
27.5
41
22
ZY010
NOMESCO Finland
Hospital outpatient
6.6
27.2
74
131
IAB08
NOMESCO Finland
Consultation concerning a patient who has attempted suicide
80.4
27.1
30
*
P15
ICPC
Chronic alcohol abuse
11.2
27.1
52
52
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
287.7
27.0
27
*
AA1AD
NOMESCO Finland
CT of head and brain
3.9
26.8
128
416
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
16.5
26.1
42
28
IGY99
NOMESCO Finland
Other psychiatric treatment contact
9.6
25.9
54
63
F10.09
ICD-10 Finland
Alcohol intoxication UNS
13.0
25.9
46
39
IFB01
NOMESCO Finland
Electroconvulsive Therapy (ECT)
47.4
25.9
31
7
N06AX12
ATC
bupropion; oral
5.9
25.8
77
153
N05AD01
ATC
haloperidol; systemic
11.8
25.8
48
45
F10.24
ICD-10 Finland
Alcohol depence active use
21.1
25.2
37
19
N05BE01
ATC
buspirone; oral
12.1
25.0
46
42
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
3.3
25.0
160
650
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
5.2
24.9
83
188
F33.30
ICD-10 Finland
Recurrent depression, severe episode without somatic syndrome
23.6
24.7
35
16
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
14.0
23.9
41
32
AA400
NOMESCO Finland
Electroconvulsive therapy
28.6
23.9
32
12
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
5.5
23.6
74
156
F19.1
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use
30.2
23.5
31
11
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
11.0
23.4
45
45
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
38.7
23.3
29
8
ZXY51
NOMESCO Finland
2-person team, doctor-nurse
12.1
22.9
42
38
IGV01
NOMESCO Finland
Psychiatric network contact
16.2
22.4
36
24
Z96.1
ICD-10 Finland
Presence of intraocular lens
30.9
22.1
29
10
P99
ICPC
Psychological disorders other
10.3
22.1
44
47
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
21.8
207
1071
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.4
21.6
59
104
F31.7
ICD-10 Finland
Bipolar affective disorder, currently in remission
13.8
21.6
37
29
IAB07
NOMESCO Finland
Consultation concerning a patient with self-harm intention
35.8
21.4
27
8
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
22.9
21.1
30
14
N03AX16
ATC
pregabalin; oral
3.3
21.1
123
459
F10.25
ICD-10 Finland
Alcohol dependence continuous use
16.9
20.9
33
21
R11
ICD-10 Finland
Nausea and vomiting
5.2
20.9
68
149
X59
ICD-10 Finland
Exposure to unspecified factor
3.3
20.9
121
449
P01
ICPC
Feeling anxious/nervous/tense
3.5
20.8
111
386
S06.0
ICD-10 Finland
Concussion
4.0
20.8
90
263
F20.9
ICD-10 Finland
Schizophrenia, unspecified
13.4
20.7
36
29
N05AH02
ATC
clozapine; systemic
12.5
20.7
37
32
F31.8
ICD-10 Finland
Other bipolar affective disorders
12.1
20.4
37
33
SPAT1240
SPAT
Therapeutic discussion
3.4
20.3
111
393
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.7
20.3
186
929
N06AX03
ATC
mianserin; oral
8.4
20.2
45
59
WX892
NOMESCO Finland
Monitored bed care
5.9
20.1
58
110
F10.9
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder
37.7
20.0
25
7
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.5
19.9
61
124
Z91.8
ICD-10 Finland
Personal history of other specified risk-factors, not elsewhere classified
+∞
19.9
19
*
F31.0
ICD-10 Finland
Bipolar affective disorder, current episode hypomanic
14.8
19.9
33
24
XF400
NOMESCO Finland
ECG with 12 standard connections
3.7
19.8
97
314
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
10.8
19.8
38
38
F19.20
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent
42.2
19.7
24
6
Z3231
NOMESCO Finland
Registered nurse
2.9
19.6
150
670
F39
ICD-10 Finland
Unspecified mood [affective] disorder
10.1
19.5
39
42
TPH04
NOMESCO Finland
Cathetrisation of vein
3.2
19.2
116
440
N05BA02
ATC
chlordiazepoxide; systemic
12.6
19.1
34
29
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
12.6
19.1
34
29
A02BC02
ATC
pantoprazole; systemic
2.5
19.1
273
1734
C03CA01
ATC
furosemide; systemic
3.3
19.0
109
399
TKC20
NOMESCO Finland
Catheterisation of bladder
6.3
18.8
51
89
F99
ICD-10 Finland
Mental disorder, not otherwise specified
9.8
18.8
38
42
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.2
18.6
113
428
N06AX21
ATC
duloxetine; oral
4.1
18.4
77
217
IFA01
NOMESCO Finland
Psychiatric pharmacotherapy plan, not specified
11.4
18.3
34
32
N06AX05
ATC
trazodone; oral
10.8
18.2
35
35
IER04
NOMESCO Finland
Rehabilitative psychiatric group intervention, functional
17.5
18.1
28
17
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.9
18.0
131
559
ZYC01
NOMESCO Finland
Remote contact by phone
5.7
18.0
53
103
ICC03
NOMESCO Finland
Psychiatric treatment plan, transfer to psychiatric ward
38.5
17.8
22
6
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
99.1
17.7
19
*
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
3.2
17.6
102
374
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
11.8
17.5
32
29
R51.80
ICD-10 Finland
Headache
3.2
17.5
105
395
F32.00
ICD-10 Finland
Mild depressive episode without somatic syndrome
5.7
17.3
51
99
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
6.2
17.2
47
83
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.7
17.2
61
146
F60.8
ICD-10 Finland
Other specific personality disorders
52.2
17.1
20
*
R07.4
ICD-10 Finland
Chest pain, unspecified
3.0
17.0
118
486
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
4.7
16.9
59
139
F43.1
ICD-10 Finland
Post-traumatic stress disorder
7.2
16.8
41
62
M79.6
ICD-10 Finland
Pain in limb
2.5
16.8
166
847
IGY02
NOMESCO Finland
Psychiatric monitoring contact
6.9
16.7
42
66
E950A
ICD-9 Finland
Suicide and self-inflicted poisoning by solid or liquid substances
24.2
16.6
23
10
N06AB05
ATC
paroxetine; oral
5.1
16.5
53
114
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
9.5
16.2
33
37
C07AB07
ATC
bisoprolol; oral
2.5
16.2
170
891
C07AB02
ATC
metoprolol; systemic
3.4
16.0
87
301
N02AX02
ATC
tramadol; systemic, rectal
2.4
16.0
179
966
F33.00
ICD-10 Finland
Recurrent depression, mild episode without somatic syndrome
10.3
15.9
31
32
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
27.5
15.7
21
8
Z03.2
ICD-10 Finland
Observation for suspected mental and behavioural disorders
10.6
15.7
30
30
Z72.2
ICD-10 Finland
Drug use
23.1
15.7
22
10
F41.1
ICD-10 Finland
Generalized anxiety disorder
4.7
15.6
54
126
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
5.0
15.6
51
112
N05AA01
ATC
chlorpromazine; systemic, rectal
16.8
15.4
24
15
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
8.3
15.4
34
44
N03AX12
ATC
gabapentin; oral
3.3
15.4
84
292
SPAT1301
SPAT
No procedures
2.5
15.3
158
817
N04AA02
ATC
biperiden; systemic
10.6
15.2
29
29
R53
ICD-10 Finland
Malaise and fatigue
2.8
15.2
116
503
A06AD11
ATC
lactulose; oral
3.6
15.0
72
227
N06AA12
ATC
doxepin; systemic
6.1
14.9
41
73
F34.1
ICD-10 Finland
Dysthymia
6.3
14.9
40
69
X58
ICD-10 Finland
Exposure to other specified factors
3.1
14.9
92
350
N06AA09
ATC
amitriptyline; systemic
4.4
14.8
55
138
Z2445
NOMESCO Finland
Psychologist
5.0
14.7
48
105
ICB02
NOMESCO Finland
Psychiatric treatment plan, extended/prolonged
14.9
14.7
24
17
P16
ICPC
Acute alcohol abuse
10.6
14.7
28
28
Z91.6
ICD-10 Finland
Personal history of other physical trauma
+∞
14.7
14
*
127
Kela drug reimbursment
Transplant complication
+∞
14.7
14
*
F19.25
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances continuously used
82.9
14.7
16
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.0
14.6
94
366
IEY08
NOMESCO Finland
Psychiatric coaching, domestic and community skills
37.4
14.5
18
5
F41.8
ICD-10 Finland
Other specified anxiety disorders
6.9
14.5
36
56
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.5
14.5
52
126
Z3226
NOMESCO Finland
Physiotherapist
2.9
14.4
98
393
IEV99
NOMESCO Finland
Other psychiatric network intervention
16.5
14.1
22
14
S51.9
ICD-10 Finland
Open wound of forearm, part unspecified
16.5
14.1
22
14
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
5.0
14.1
46
101
P03
ICPC
Feeling depressed
3.1
14.0
83
305
R50.9
ICD-10 Finland
Fever, unspecified
3.1
13.9
85
317
P76
ICPC
Depressive disorder
4.0
13.9
58
162
P18
ICPC
Medication abuse
24.7
13.9
19
8
P74
ICPC
Anxiety disorder/anxiety state
5.0
13.9
45
98
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
12.6
13.7
24
20
Y19
ICD-10 Finland
Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent
77.6
13.7
15
*
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
7.0
13.5
33
50
F10.23
ICD-10 Finland
Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication
26.7
13.5
18
7
K59.09
ICD-10 Finland
Constipation, unspecified
5.2
13.4
42
88
N05BA12
ATC
alprazolam; oral
3.6
13.4
63
195
B18.2
ICD-10 Finland
Chronic viral hepatitis C
14.4
13.4
22
16
V03AA01
ATC
NA
12.7
13.2
23
19
SPAT1309
SPAT
Guidance related to psychoactive substances / risk behaviour
6.2
13.2
35
60
F31.5
ICD-10 Finland
Bipolar affective disorder, current episode severe depression with psychotic symptoms
29.4
13.0
17
6
F92.0
ICD-10 Finland
Depressive conduct disorder
29.4
13.0
17
6
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.1
13.0
76
275
IBZ02
NOMESCO Finland
Somatic assessment of psychiatric patient
23.4
13.0
18
8
R55
ICD-10 Finland
Syncope and collapse
3.6
13.0
60
183
P06
ICPC
Sleep disturbance
3.4
12.9
65
212
ZXD05
NOMESCO Finland
Urgent procedure
2.3
12.8
159
884
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
12.8
76
279
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.6
12.8
60
185
A02BA02
ATC
ranitidine; systemic
2.9
12.8
86
342
F25.9
ICD-10 Finland
Schizoaffective disorder, unspecified
12.8
12.7
22
18
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.7
12.7
100
437
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.5
12.7
45
108
IEY01
NOMESCO Finland
Psychoeducation, individual
13.7
12.6
21
16
ZYB04
NOMESCO Finland
Outreach service in patient’s home or everyday environment
20.8
12.5
18
9
F19.29
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances UNS
25.2
12.5
17
7
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
6.6
12.5
32
52
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.3
12.5
47
119
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.9
12.4
81
316
A01
ICPC
Pain general/multiple sites
4.0
12.3
50
136
T74.1
ICD-10 Finland
Physical abuse
7.3
12.3
29
42
Z72.1
ICD-10 Finland
Alcohol use
12.9
12.2
21
17
ZXY49
NOMESCO Finland
Other health care provider
18.7
12.1
18
10
F61
ICD-10 Finland
Mixed and other personality disorders
27.6
12.1
16
6
N05AF01
ATC
flupentixol; systemic
13.9
12.1
20
15
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.2
12.0
152
844
N05CF02
ATC
zolpidem; oral
2.7
12.0
92
397
Z00.0
ICD-10 Finland
General medical examination
2.6
12.0
101
458
F33.8
ICD-10 Finland
Other recurrent depressive disorders
15.2
11.9
19
13
Z76.8
ICD-10 Finland
Persons encountering health services in other specified circumstances
6.1
11.9
32
56
103
Kela drug reimbursment
Diabetes, insulin-treated
2.5
11.9
103
475
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
8.1
11.8
26
34
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
11.8
84
345
F10.40
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without seizures
31.0
11.7
15
5
S18
ICPC
Laceration/cut
2.1
11.7
175
1047
A02BC01
ATC
omeprazole; systemic
2.3
11.7
123
625
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
11.7
45
117
F13.1
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use
19.6
11.7
17
9
X61
ICD-10 Finland
Intentional self-poisoning by and exposure to antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified
66.7
11.7
13
*
P77
ICPC
Suicide/suicide attempt
66.7
11.7
13
*
J01FF01
ATC
clindamycin; systemic
2.3
11.7
123
627
M54.5
ICD-10 Finland
Low back pain
2.2
11.6
159
913
SPAT1254
SPAT
Administration of medicine
2.7
11.6
84
350
XF600
NOMESCO Finland
Bloodpressure measurement
4.0
11.5
46
124
Z91.3
ICD-10 Finland
Personal history of unhealthy sleep-wake schedule
123.1
11.5
12
*
R06.0
ICD-10 Finland
Dyspnoea
2.5
11.5
105
496
Z2221
NOMESCO Finland
Medical doctor
2.2
11.4
138
748
N05AE04
ATC
ziprasidone; systemic
15.6
11.4
18
12
T90
ICPC
Diabetes non-insulin dependent
2.6
11.4
88
380
F19.21
ICD-10 Finland
Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment
36.0
11.3
14
*
ZYY79
NOMESCO Finland
Other indirect service without contact with patient
36.0
11.3
14
*
F51.0
ICD-10 Finland
Nonorganic insomnia
2.7
11.3
82
341
N30.0
ICD-10 Finland
Acute cystitis
2.8
11.2
78
317
ZXY60
NOMESCO Finland
2-person team, nurses
11.6
11.1
20
18
A03FA01
ATC
metoclopramide; systemic, rectal
2.6
11.1
91
406
D12
ICPC
Constipation
7.2
11.0
26
38
F13.22
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication
44.5
11.0
13
*
RS220
NOMESCO Finland
NA
12.3
10.9
19
16
N06AX26
ATC
vortioxetine; oral
3.6
10.9
49
146
SPAT1260
SPAT
Consultation of another employee
2.5
10.8
92
418
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
10.7
64
233
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.2
10.7
41
106
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.2
10.6
56
189
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
5.7
10.6
30
56
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
10.6
49
150
R42
ICD-10 Finland
Dizziness and giddiness
2.5
10.6
88
394
F50.9
ICD-10 Finland
Eating disorder, unspecified
8.0
10.5
23
30
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.4
10.5
95
447
Z94.0
ICD-10 Finland
Kidney transplant status
+∞
10.5
10
*
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
2.6
10.4
85
377
188
Kela drug reimbursment
Psychosis requiring demanding treatment
16.5
10.4
16
10
F25.10
ICD-10 Finland
Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms
16.5
10.4
16
10
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.5
10.4
92
425
F32.1
ICD-10 Finland
Moderate depressive episode
3.6
10.4
47
141
Z71.8
ICD-10 Finland
Other specified counselling
2.2
10.4
133
734
ZXY56
NOMESCO Finland
2-person team, nurse-psychologist
33.4
10.4
13
*
IFA99
NOMESCO Finland
Other psychiatric pharmacotherapy service
11.0
10.4
19
18
F31
ICD-10 Finland
Bipolar affective disorder
9.9
10.4
20
21
N03AF01
ATC
carbamazepine; oral, rectal
5.1
10.3
32
67
9694A
ICD-9 Finland
Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers
24.0
10.3
14
6
SPAT1227
SPAT
Substance abuse rehabilitation
13.5
10.2
17
13
P72
ICPC
Schizophrenia
8.2
10.2
22
28
NA1AD
NOMESCO Finland
Cervical spine CT examination
4.8
10.1
33
73
IER01
NOMESCO Finland
Psychoeducation, group
10.4
10.1
19
19
A10BA02
ATC
metformin; oral
2.3
10.1
101
497
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.5
10.1
47
145
Z3229
NOMESCO Finland
Other healthcare associate professional
3.4
10.0
48
151
T65.9
ICD-10 Finland
Toxic effect: Toxic effect of unspecified substance
41.0
10.0
12
*
3018X
ICD-9 Finland
Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]
41.0
10.0
12
*
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
6.6
10.0
25
40
K92.1
ICD-10 Finland
Melaena
5.1
10.0
31
65
I25.2
ICD-10 Finland
Old myocardial infarction
6.2
10.0
26
44
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.3
9.9
51
169
IEY21
NOMESCO Finland
Other intensified psychiatric treatment
17.2
9.9
15
9
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
7.3
9.9
23
33
F41.09
ICD-10 Finland
UNS Panic Syndrome
4.7
9.9
33
75
SPAT1265
SPAT
Breathalyser
11.0
9.9
18
17
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.8
9.9
42
120
11
HP
Coronary artery bypass surgery
20.6
9.9
14
7
P73
ICPC
Affective psychosis
20.6
9.9
14
7
3018D
ICD-9 Finland
Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]
20.6
9.9
14
7
A04
ICPC
Weakness/tiredness general
2.6
9.8
74
314
N06AX22
ATC
agomelatine; oral
6.1
9.8
26
45
X57
ICD-10 Finland
Unspecified privation
7.7
9.8
22
30
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.4
9.8
35
85
IGP01
NOMESCO Finland
Psychiatric family contact
13.8
9.7
16
12
F40.1
ICD-10 Finland
Social phobias
5.5
9.7
28
54
F10.02
ICD-10 Finland
Alcohol-related acute intoxication with other acute clinical complications
56.2
9.7
11
*
81
HP
Angiography of the heart and coronary arteries
5.9
9.7
26
46
Z00.8
ICD-10 Finland
Other general examinations
3.3
9.6
48
156
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
9.6
85
393
W19
ICD-10 Finland
Unspecified fall
2.9
9.6
60
228
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.5
9.6
44
134
F20.09
ICD-10 Finland
Paranoid schizophrenia UNS
15.5
9.6
15
10
N02BE01
ATC
paracetamol; systemic, rectal
2.1
9.6
355
2921
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.9
9.5
189
1236
F93.89
ICD-10 Finland
Other childhood emotional disorders
7.8
9.5
21
28
N06AB08
ATC
fluvoxamine; oral
6.4
9.5
24
39
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.9
9.5
194
1281
Z86.4
ICD-10 Finland
Personal history of psychoactive substance abuse
102.1
9.4
10
*
F10.03
ICD-10 Finland
Alcohol-related acute intoxication with delirium
102.1
9.4
10
*
4120B
ICD-9 Finland
Old myocardial infarction[STATUS POST INFARCTUM CORDIS,AHTAUTUNUT]
30.7
9.4
12
*
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.3
9.4
103
526
ICC04
NOMESCO Finland
Psychiatric treatment plan, permanent discontinuation
5.3
9.4
28
56
F19.24
ICD-10 Finland
Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction
22.3
9.4
13
6
F60.0
ICD-10 Finland
Paranoid personality disorder
22.3
9.4
13
6
C01DA14
ATC
isosorbide mononitrate; oral
3.4
9.4
45
142
SPAT1243
SPAT
Psychiatric/psychological examination
4.2
9.4
35
89
E16.2
ICD-10 Finland
Hypoglycaemia, unspecified
9.8
9.3
18
19
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
2.1
9.3
116
631
R33
ICD-10 Finland
Retention of urine
3.9
9.3
38
105
A02BC03
ATC
lansoprazole; oral
2.1
9.2
115
623
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.9
9.2
57
214
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.5
9.2
32
76
R03BB04
ATC
tiotropium bromide; inhalant
3.4
9.2
44
139
F25.20
ICD-10 Finland
Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms
16.0
9.1
14
9
WX882
NOMESCO Finland
High dependency care
6.7
9.1
22
34
R05
ICPC
Cough
2.1
9.1
112
605
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
6.3
9.0
23
38
SPAT1294
SPAT
Other function in accordance with health social work nomenclature
7.7
9.0
20
27
F23.99
ICD-10 Finland
Acute and transient psychosis, unspecified UNS
24.6
8.9
12
5
ZYY01
NOMESCO Finland
Contact between professionals
24.6
8.9
12
5
2968A
ICD-9 Finland
Affective psychoses, Manic-depressive psychosis, other and unspecified
24.6
8.9
12
5
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
12.9
8.9
15
12
N06CA01
ATC
amitriptyline and psycholeptics; systemic
3.1
8.9
50
176
R02
ICPC
Shortness of breath/dyspnoea
2.8
8.9
58
225
A46
ICD-10 Finland
Erysipelas
2.9
8.8
55
208
I20.90
ICD-10 Finland
Angina pectoris, unspecified
7.4
8.8
20
28
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
8.8
67
285
N05AL01
ATC
sulpiride; systemic
14.4
8.7
14
10
Z95.5
ICD-10 Finland
Presence of coronary angioplasty implant and graft
51.0
8.7
10
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.7
8.7
59
236
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.7
8.7
59
236
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.8
8.7
223
1581
N07BA03
ATC
varenicline; oral
4.0
8.7
34
91
R52.2
ICD-10 Finland
Other chronic pain
5.1
8.6
26
53
R52.9
ICD-10 Finland
Pain, unspecified
3.0
8.6
49
174
A06AC01
ATC
ispaghula (psylla seeds); oral
2.2
8.6
98
509
R07.3
ICD-10 Finland
Other chest pain
3.3
8.6
43
140
SPAT1312
SPAT
General health counselling
1.9
8.6
165
1057
F10.22
ICD-10 Finland
Alcohol dependence is currently on clinically controlled discontinuation medication
16.7
8.6
13
8
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
5.6
8.6
24
45
N30.9
ICD-10 Finland
Cystitis, unspecified
3.8
8.6
35
97
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
3.2
8.5
44
147
R4110
NOMESCO Finland
Physiotherapy
2.1
8.5
105
566
ZXY59
NOMESCO Finland
2-person team, nurse-other special worker
28.1
8.5
11
*
T51.0
ICD-10 Finland
Toxic effect: Ethanol
20.5
8.5
12
6
U05
ICPC
Urination problems other
5.2
8.5
25
50
G43.9
ICD-10 Finland
Migraine, unspecified
3.1
8.4
45
154
WX110
NOMESCO Finland
Local anesthesy
1.9
8.4
309
2456
F41.00
ICD-10 Finland
Moderate panic disorder
5.7
8.4
23
42
N05AC02
ATC
thioridazine; oral
6.0
8.4
22
38
K04.0
ICD-10 Finland
Pulpitis
2.6
8.4
62
260
L17
ICPC
Foot/toe symptom/complaint
2.1
8.4
111
617
Z94.1
ICD-10 Finland
Heart transplant status
+∞
8.4
8
*
F32
ICD-10 Finland
Depressive episode
3.2
8.3
43
144
R03AC02
ATC
salbutamol; inhalant
1.8
8.3
225
1615
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
3.1
8.3
44
150
S60.2
ICD-10 Finland
Contusion of other parts of wrist and hand
3.8
8.3
34
95
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
5.6
8.3
23
43
F44.9
ICD-10 Finland
Dissociative [conversion] disorder, unspecified
14.8
8.2
13
9
P27
ICPC
Fear of mental disorder
7.8
8.2
18
24
L12
ICPC
Hand/finger symptom/complaint
2.4
8.2
72
330
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.9
8.2
49
181
L28
ICPC
Limited function/disability (L)
2.7
8.1
58
238
SPAT1307
SPAT
Psychosocial counselling and guidance
2.7
8.1
58
238
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
2.5
8.1
67
299
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
12.0
8.1
14
12
IAB01
NOMESCO Finland
Psychiatric pharmacotherapy consultation
12.0
8.1
14
12
R44.3
ICD-10 Finland
Hallucinations, unspecified
17.6
8.1
12
7
S80.0
ICD-10 Finland
Contusion of knee
3.2
8.0
41
136
IEY15
NOMESCO Finland
Acute psychiatry, stabilising intervention
22.5
8.0
11
5
ZXY83
NOMESCO Finland
Social worker in multidisciplinary team
22.5
8.0
11
5
K92.0
ICD-10 Finland
Haematemesis
7.5
8.0
18
25
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.9
8.0
152
966
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.4
8.0
37
114
M54.4
ICD-10 Finland
Lumbago with sciatica
2.4
8.0
73
342
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
8.0
46
166
ZYD01
NOMESCO Finland
Emergency clinic
13.3
7.9
13
10
F31.1
ICD-10 Finland
Bipolar affective disorder, current episode manic without psychotic symptoms
13.3
7.9
13
10
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.2
7.9
40
132
N03AX11
ATC
topiramate; oral
4.6
7.9
26
59
P01AB01
ATC
metronidazole; oral, rectal
1.8
7.8
163
1067
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
4.1
7.8
29
74
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
7.8
139
862
N02AA05
ATC
oxycodone; systemic
2.8
7.8
50
194
D10
ICPC
Vomiting
3.0
7.8
45
163
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
7.8
62
272
F11.22
ICD-10 Finland
Addiction-induced dependence is currently independent but uses substitute intermittent medication
15.4
7.8
12
8
F19.2
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome
45.8
7.7
9
*
F19.9
ICD-10 Finland
Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder
45.8
7.7
9
*
F19.00
ICD-10 Finland
Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated
45.8
7.7
9
*
F25.1
ICD-10 Finland
Schizoaffective disorder, depressive type
45.8
7.7
9
*
S51.7
ICD-10 Finland
Multiple open wounds of forearm
45.8
7.7
9
*
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.5
7.7
62
273
S61.8
ICD-10 Finland
Open wound of other parts of wrist and hand
5.1
7.7
23
47
I20.99
ICD-10 Finland
Angina pectoris, unspecified
4.7
7.7
25
56
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
7.7
319
2597
D11
ICPC
Diarrhoea
2.4
7.7
69
322
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.0
7.6
116
677
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
18.7
7.6
11
6
IEZ99
NOMESCO Finland
Other psychiatric rehabilitation intervention
18.7
7.6
11
6
W10
ICD-10 Finland
Fall on and from stairs and steps
3.9
7.6
30
81
N05AD03
ATC
melperone; systemic
12.1
7.6
13
11
IEY06
NOMESCO Finland
Psychiatric treatment and rehabilitation coaching
25.5
7.6
10
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.9
7.6
47
176
F31.3
ICD-10 Finland
Bipolar affective disorder, current episode mild or moderate depression
10.3
7.6
14
14
I50.9
ICD-10 Finland
Heart failure, unspecified
3.2
7.6
39
131
C10AA01
ATC
simvastatin; oral
1.9
7.5
117
690
WX002
NOMESCO Finland
Sedation and analgesia
2.3
7.5
74
359
RS221
NOMESCO Finland
NA
7.9
7.4
16
21
ZXE00
NOMESCO Finland
One hour or less
1.8
7.4
168
1126
F34.0
ICD-10 Finland
Cyclothymia
13.7
7.4
12
9
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
3.5
7.4
33
99
K59.0
ICD-10 Finland
Constipation
4.0
7.4
28
73
SPAT1262
SPAT
Handing over of treatment supplies
2.3
7.4
69
326
F05.9
ICD-10 Finland
Delirium, unspecified
8.6
7.4
15
18
SPAT1234
SPAT
Support of social functional capacity
3.8
7.3
30
84
N05CD02
ATC
nitrazepam; oral
9.6
7.3
14
15
F10.0
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Acute intoxication
9.6
7.3
14
15
B01AC04
ATC
clopidogrel; oral
3.0
7.3
42
151
N01
ICPC
Headache
2.3
7.3
73
356
SPAT1249
SPAT
Treatment-related counselling outside office
1.8
7.3
181
1247
Z97.4
ICD-10 Finland
Presence of external hearing-aid
+∞
7.3
7
*
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
+∞
7.3
7
*
X70
ICD-10 Finland
Intentional self-harm by hanging, strangulation and suffocation
+∞
7.3
7
*
F43.00
ICD-10 Finland
Acute stress reaction mild
4.8
7.3
23
50
N06AA06
ATC
trimipramine; systemic
5.6
7.3
20
37
G47.3
ICD-10 Finland
Sleep apnoea
2.2
7.3
79
399
S29
ICPC
Skin symptom/complaint other
2.2
7.3
79
401
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
7.5
7.2
16
22
B01AC06
ATC
acetylsalicylic acid; oral (platelet aggregation inhibitors excl. heparin)
7.5
7.2
16
22
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.6
7.2
55
233
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.4
7.2
34
107
D64.9
ICD-10 Finland
Anaemia, unspecified
3.1
7.2
38
130
S61.9
ICD-10 Finland
Open wound of wrist and hand, part unspecified
4.7
7.2
23
51
F19.09
ICD-10 Finland
Intoxication caused by several drugs in combination and by other psychoactive substances UNS
30.5
7.2
9
*
F60.2
ICD-10 Finland
Dissocial personality disorder
30.5
7.2
9
*
A02BC05
ATC
esomeprazole; systemic
1.8
7.2
148
958
IEY19
NOMESCO Finland
Psychiatric health counselling and guidance
20.4
7.2
10
5
IDR03
NOMESCO Finland
Systematic group therapy, dialectical behaviour therapy (DBT)
20.4
7.2
10
5
R20.2
ICD-10 Finland
Paraesthesia of skin
3.0
7.1
40
140
R4120
NOMESCO Finland
Occupational therapy
3.1
7.1
38
131
N05AB01
ATC
dixyrazine; systemic
12.3
7.1
12
10
WX704
NOMESCO Finland
Intubation
3.0
7.1
40
141
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
3.2
7.1
35
114
S09.9
ICD-10 Finland
Unspecified injury of head
9.0
7.1
14
16
N05AF05
ATC
zuclopenthixol; systemic
10.3
7.1
13
13
-1
NOMESCO Finland
NA
1.8
7.1
175
1200
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
7.2
7.1
16
23
SPAT1229
SPAT
Assessment of need for aid
3.4
7.0
32
98
J01DB01
ATC
cefalexin; oral
1.9
7.0
347
2934
SGA01
NOMESCO Finland
Tooth opening as first aid
2.1
7.0
78
401
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.9
7.0
41
150
Z53.2
ICD-10 Finland
Procedure not carried out because of patient's decision for other and unspecified reasons
6.5
7.0
17
27
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
3.1
6.9
36
122
R44.0
ICD-10 Finland
Auditory hallucinations
14.1
6.9
11
8
Z04.4
ICD-10 Finland
Examination and observation following alleged rape and seduction
14.1
6.9
11
8
F13.29
ICD-10 Finland
Addiction caused by sedative and hypnotic UNS
14.1
6.9
11
8
A28
ICPC
Limited function/disability NOS
2.6
6.9
48
195
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.8
6.9
43
161
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
4.0
6.9
26
68
E86
ICD-10 Finland
Volume depletion
6.9
6.9
16
24
K04.4
ICD-10 Finland
Acute apical periodontitis of pulpal origin
2.7
6.8
47
189
R4140
NOMESCO Finland
Psychotherapy
11.2
6.8
12
11
Z08
ICPC
Social welfare problem
9.5
6.8
13
14
IBA02
NOMESCO Finland
Evaluation of need for psychiatric rehabilitation
9.5
6.8
13
14
P28
ICPC
Limited function/disability (P)
9.5
6.8
13
14
ZYD04
NOMESCO Finland
Emergency outreach service, another specialty
40.7
6.8
8
*
F13.3
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state
40.7
6.8
8
*
F44.7
ICD-10 Finland
Mixed dissociative [conversion] disorders
40.7
6.8
8
*
IAB11
NOMESCO Finland
Psychiatric mood consultation
17.0
6.8
10
6
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
4.6
6.7
22
50
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
6.7
229
1721
SPAT1310
SPAT
Counselling related to known health issue
1.8
6.7
146
959
WX290
NOMESCO Finland
Other blockade of nerve
1.7
6.7
224
1671
F13.20
ICD-10 Finland
Addiction relationship caused by sedatives and hypnotics currently independent
22.9
6.7
9
*
SPAT1241
SPAT
Extensive assessment of psychosocial situation
6.6
6.7
16
25
F41.3
ICD-10 Finland
Other mixed anxiety disorders
5.6
6.7
18
33
R96
ICPC
Asthma
2.7
6.7
44
174
P19
ICPC
Drug abuse
8.0
6.7
14
18
S50.1
ICD-10 Finland
Contusion of other and unspecified parts of forearm
8.0
6.7
14
18
I10
ICD-10 Finland
Essential (primary) hypertension
1.7
6.6
161
1093
F21
ICD-10 Finland
Schizotypal disorder
12.5
6.6
11
9
M25.5
ICD-10 Finland
Pain in joint
1.8
6.6
122
758
EBA00
NOMESCO Finland
Extraction of tooth
1.7
6.6
157
1061
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
10.2
6.6
12
12
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
10.2
6.6
12
12
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
7.0
6.6
15
22
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
6.3
6.5
16
26
F20.30
ICD-10 Finland
Undifferentiated schizophrenia continuous
6.3
6.5
16
26
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
6.5
109
654
F90.0
ICD-10 Finland
Disturbance of activity and attention
3.5
6.5
29
88
K04.08
ICD-10 Finland
Other specified pulpit
2.8
6.5
41
157
S00.8
ICD-10 Finland
Superficial injury of other parts of head
7.6
6.5
14
19
K08.3
ICD-10 Finland
Retained dental root
3.1
6.4
33
111
F20.5
ICD-10 Finland
Residual schizophrenia
70.8
6.4
7
*
9691A
ICD-9 Finland
Poisoning by psychotropic agents, Phenothiazine-based tranquillisers
70.8
6.4
7
*
IAB12
NOMESCO Finland
Psychiatric psychosis consultation
70.8
6.4
7
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
6.4
78
416
S10
ICPC
Boil/carbuncle
3.1
6.4
34
117
S01.1
ICD-10 Finland
Open wound of eyelid and periocular area
5.0
6.4
19
39
A07AA02
ATC
nystatin; oral
3.6
6.4
27
78
ZXY80
NOMESCO Finland
Doctor in multidisciplinary team
14.6
6.4
10
7
Y04.9
ICD-10 Finland
Assault by bodily force by unknown person
14.6
6.4
10
7
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
8.3
6.4
13
16
I20.01
ICD-10 Finland
Unstable angina
8.3
6.4
13
16
S01.0
ICD-10 Finland
Open wound of scalp
2.9
6.4
37
135
L03.9
ICD-10 Finland
Cellulitis, unspecified
5.7
6.4
17
31
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.9
6.3
100
589
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.5
6.3
50
217
TPW99
NOMESCO Finland
Other minor surgical procedure on peripheral vessel or lymphatic system
11.2
6.3
11
10
F25.00
ICD-10 Finland
Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms
11.2
6.3
11
10
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
11.2
6.3
11
10
I20.09
ICD-10 Finland
Unstable angina
4.9
6.3
19
40
F25.11
ICD-10 Finland
Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms
18.3
6.3
9
5
Z03
ICPC
Housing/neighbourhood problem
18.3
6.3
9
5
F23.3
ICD-10 Finland
Other acute predominantly delusional psychotic disorders
18.3
6.3
9
5
ZXY57
NOMESCO Finland
2-person team, nurse-social worker
18.3
6.3
9
5
SPAT1058
SPAT
PEF monitoring instruction
2.8
6.3
38
143
UKC02
NOMESCO Finland
Cystoscopy
2.3
6.3
57
264
R00.0
ICD-10 Finland
Tachycardia, unspecified
3.9
6.3
24
64
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.2
6.3
66
328
ZXY01
NOMESCO Finland
Chief Physician, Head of Department or Deputy Chief Physician
7.2
6.3
14
20
JN3AD
NOMESCO Finland
Abdominal CT examination
3.2
6.3
31
102
L01BB01
ATC
NA
+∞
6.3
6
*
Z91.4
ICD-10 Finland
Personal history of psychological trauma, not elsewhere classified
+∞
6.3
6
*
F13.9
ICD-10 Finland
Mental and behavioural disorders due to use of sedatives or hypnotics, unspecified mental and behavioural disorder
+∞
6.3
6
*
T40.4
ICD-10 Finland
Poisoning: Other synthetic narcotics
+∞
6.3
6
*
IBZ07
NOMESCO Finland
Neurological assessment in psychiatry
+∞
6.3
6
*
A10AE04
ATC
insulin glargine; parenteral
2.9
6.3
37
137
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
3.5
6.2
27
80
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
2.4
6.2
50
220
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
5.9
6.2
16
28
C07AA07
ATC
sotalol; systemic
5.9
6.2
16
28
U04
ICPC
Incontinence urine
4.2
6.2
22
55
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
6.2
152
1033
D01
ICPC
Abdominal pain/cramps general
2.1
6.2
66
334
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.3
6.1
57
270
WX872
NOMESCO Finland
Intensive care
4.5
6.1
20
46
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
6.1
56
261
ZXY82
NOMESCO Finland
Nurse in multidisciplinary team
12.7
6.1
10
8
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.7
6.1
40
158
F31.20
ICD-10 Finland
Bipolar disorder, manic episode with mood-congruent psychotic symptoms
8.8
6.1
12
14
IBB02
NOMESCO Finland
Psychiatric evaluation of working capacity and rehabilitation
8.8
6.1
12
14
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.9
6.1
23
61
N06AG02
ATC
moclobemide; oral
3.9
6.1
23
61
F22.0
ICD-10 Finland
Delusional disorder
10.2
6.1
11
11
Z72.0
ICD-10 Finland
Tobacco use
4.7
6.0
19
42
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
4.7
6.0
19
42
WVA20
NOMESCO Finland
Medicine administration
5.7
6.0
16
29
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
4.4
6.0
20
47
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4198724)
71
22
37.53
112.11
3.5
2.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
64
16
45.82
106.83
7.0
2.2
umol/l
216.3
97.3
—
37
7
(3028707) Methadone [Presence] in Urine by Screen method
111
141
9.87
85.28
4.0
2.1
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
59
28
23.80
79.94
2.6
1.4
promille
1.7
1.3
0.63
49
22
(1001926) Buprenorphine [Presence] in Urine by Screen method
131
249
6.80
69.81
3.7
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
120
218
6.95
66.67
3.4
2.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
199
577
5.11
66.03
3.5
1.8
%
1.7
1.4
5.30
179
525
(3016879) Cocaine [Presence] in Urine
136
291
6.07
63.76
3.9
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
137
310
5.74
60.19
3.9
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
137
314
5.66
59.27
3.9
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
292
1219
4.42
58.58
5.9
3.0
u/l
30.3
30.4
0.02
279
1165
(3027008) Opiates [Presence] in Urine
135
312
5.58
57.75
3.9
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
133
312
5.47
55.80
3.9
1.7
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
56
61
10.23
47.46
7.5
5.5
umol/l
378.0
367.3
0.18
49
50
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
246
1020
3.82
47.31
5.5
2.3
u/l
49.5
55.6
2.36
236
941
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
225
894
3.79
45.85
3.5
2.0
u/l
293.0
242.3
0.22
217
848
(3002032) Base excess in Venous blood by calculation
114
276
5.07
45.47
6.1
4.4
mmol/l
1.6
1.7
0.22
98
216
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
293
1393
3.72
45.09
9.1
5.2
mmol/l
1.2
1.2
1.33
278
1271
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
329
1699
3.82
44.24
9.0
5.1
umol/l
8.7
11.2
6.75
316
1601
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
306
1532
3.63
42.67
10.5
5.7
mmol/l
1.2
1.2
1.52
273
1312
(3023368) Bacteria identified in Blood by Culture
199
766
3.68
41.88
5.6
3.6
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
113
298
4.62
40.28
8.1
7.6
mmol/l
1.0
1.1
0.15
85
236
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
145
473
3.93
38.65
2.3
1.7
—
—
—
0
0
(3000991) Gas panel - Venous blood
102
258
4.72
38.19
9.5
8.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
72
136
6.03
37.54
7.9
10.5
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
348
1996
3.53
36.88
9.2
4.1
mmol/l
6.5
6.4
0.27
337
1792
(3032080) INR in Blood by Coagulation assay
236
1088
3.24
36.01
8.8
6.0
inr
1.1
1.1
1.40
91
338
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
114
332
4.17
35.36
2.3
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
114
334
4.14
35.05
2.3
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
177
709
3.33
33.83
1.7
1.4
nmol/l
16.4
21.0
4.91
163
605
(3018418) pH of Serum or Plasma
205
916
3.12
32.28
5.4
3.1
ph
7.4
7.4
0.62
40
148
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
146
534
3.46
32.12
4.7
2.7
ng/l
258.0
277.5
0.04
96
347
(3024561) Albumin [Mass/volume] in Serum or Plasma
257
1316
2.99
31.48
6.7
4.3
g/l
35.5
36.5
1.78
242
1228
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
399
2667
3.60
29.44
11.6
6.1
u/l
80.3
78.2
0.42
389
2494
(3026782) Osmolality of Urine
155
634
3.11
27.85
4.0
2.4
mosm/kgh2o
499.2
578.8
3.21
140
528
(42870588) Differential panel, method unspecified - Blood
238
1229
2.81
27.77
7.9
5.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
47
80
6.39
27.02
6.5
5.2
mmol/l
1.3
1.2
0.38
41
69
(3002582) Erythrocytes [#/volume] in Urine
209
1030
2.79
26.39
4.8
2.8
e6/l
32.6
91.5
1.07
177
761
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
217
1101
2.73
25.75
5.2
2.9
ng/l
27.9
27.0
0.04
137
601
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
69
173
4.47
25.70
5.5
5.0
mmol/l
24.3
24.2
0.22
63
159
(3015377) Calcium [Moles/volume] in Serum or Plasma
210
1051
2.74
25.56
3.5
2.6
mmol/l
2.3
2.4
0.94
189
921
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
70
179
4.39
25.42
2.0
1.4
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
233
1235
2.68
25.20
2.3
1.8
pmol/l
94.6
94.9
0.04
150
629
(3007853) Bacteria identified in Skin by Aerobe culture
112
400
3.33
25.03
1.8
1.5
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
200
985
2.73
25.02
3.8
3.3
mmol/l
6.4
8.3
5.00
169
850
(3019309) Folate [Moles/volume] in Red Blood Cells
124
476
3.14
24.53
1.9
1.6
nmol/l
1028.2
1209.0
1.32
102
364
(3001604) Monocytes [#/volume] in Blood
310
1909
2.68
24.40
8.9
5.6
e9/l
0.6
0.6
4.71
281
1677
(3006315) Basophils [#/volume] in Blood
310
1915
2.67
24.14
9.0
5.6
e9/l
0.0
0.0
0.16
281
1686
(3013650) Neutrophils [#/volume] in Blood by Automated count
339
2192
2.75
23.99
15.4
8.3
e9/l
4.3
4.0
1.27
311
1913
(3033658) Prothrombin time (PT) actual/Normal
179
848
2.74
23.99
8.0
3.4
%
91.7
93.8
0.55
170
829
(3013115) Eosinophils [#/volume] in Blood
316
1985
2.65
23.53
10.1
6.0
e9/l
0.2
0.2
0.68
290
1775
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
222
1197
2.55
22.56
5.1
2.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
197
1005
2.60
22.47
3.9
2.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
314
1995
2.58
22.36
9.1
5.5
e9/l
2.1
2.0
1.31
287
1786
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
47
96
5.31
22.28
6.6
5.4
%
2.9
1.6
3.47
47
86
(3030467) Casts [#/volume] in Urine by Automated count
186
932
2.60
21.91
4.6
2.8
e6/l
0.4
0.3
0.11
154
674
(3000850) Epithelial cells [#/volume] in Urine
150
679
2.74
21.65
3.7
2.3
e6/l
9.1
7.3
0.41
131
581
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
35
55
6.77
21.65
2.0
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
185
936
2.56
21.24
9.4
6.1
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
282
1738
2.45
20.94
9.2
5.7
%
0.6
0.7
2.79
275
1627
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
135
590
2.77
20.76
1.7
1.6
pmol/l
106140784.9
26459560.4
0.34
114
514
(3019060) Gas panel - Arterial blood
60
161
4.10
20.33
6.2
4.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
124
526
2.81
20.13
3.9
2.7
e6/l
6.4
2.7
2.27
76
277
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
379
2708
2.73
20.00
7.3
2.8
u/l
55.8
39.1
3.38
366
2579
(3019069) Monocytes/100 leukocytes in Blood
287
1808
2.41
19.92
9.3
5.8
%
8.6
8.2
1.22
281
1704
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
103
400
2.99
19.63
4.6
2.4
umol/l
4.8
8.7
2.20
90
335
(3018095) Leukocytes [#/volume] in Urine
224
1274
2.39
19.55
6.1
3.2
e6/l
29.3
93.7
1.52
182
824
(3006504) Eosinophils/100 leukocytes in Blood
284
1801
2.36
19.14
9.1
5.5
%
2.6
2.7
0.37
278
1683
(3014007) Fractional oxyhemoglobin in Arterial blood
61
173
3.88
19.12
9.1
9.4
%
92.3
94.6
1.45
61
173
(3002030) Lymphocytes/100 leukocytes in Blood
292
1883
2.35
18.80
9.0
5.5
%
29.5
29.7
0.09
286
1775
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
91
338
3.08
18.70
3.7
2.1
u/l
31.8
33.8
0.09
79
280
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
401
2997
2.81
18.43
5.5
3.8
pmol/l
14.2
14.5
2.08
375
2736
(3019150) Specific gravity of Urine by Refractometry
166
846
2.45
18.30
5.0
3.3
kg/l
1.0
1.0
0.73
18
97
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
78
269
3.26
18.14
4.7
2.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
104
430
2.80
17.53
2.2
1.9
g/l
2.3
2.4
0.98
95
395
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
167
868
2.40
17.49
2.7
2.1
mg/l
2.7
2.8
0.24
153
734
(36304419) Bacteria [Presence] in Urine
175
931
2.36
17.36
4.7
2.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
45
110
4.40
17.18
1.5
1.3
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
112
488
2.68
17.01
2.3
1.9
umol/l
12.2
14.2
2.07
104
447
(3023511) Choriogonadotropin [Units/volume] in Urine
59
178
3.63
16.87
2.1
1.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
97
397
2.80
16.61
2.3
1.9
%
20.1
24.0
1.72
83
357
(3018010) Neutrophils/100 leukocytes in Blood
283
1863
2.22
16.51
9.2
5.3
%
56.1
56.0
0.05
277
1760
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
39
88
4.73
16.42
2.1
1.8
ug/l
2.6
1.3
0.29
39
77
(3021901) Oxygen saturation in Capillary blood
29
50
6.10
16.37
4.1
2.1
—
—
—
0
0
(3044889) 12 lead EKG panel
331
2329
2.28
16.27
4.7
3.0
—
—
—
0
0
(3009343) pH of Capillary blood
64
209
3.37
16.19
4.2
4.0
ph
7.4
7.4
0.20
11
20
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
78
288
3.03
16.08
2.6
2.7
g/l
0.2
0.2
0.58
73
270
(3039000) Anion gap in Blood
29
51
5.98
16.04
7.5
6.2
mmol/l
11.1
11.6
0.22
29
45
(3018572) Chloride [Moles/volume] in Blood
29
51
5.98
16.04
7.6
6.2
mmol/l
105.6
106.0
0.13
29
45
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
63
205
3.38
16.02
4.2
4.0
mmol/l
1.4
1.7
0.24
44
150
(3031040) Bacteria [#/volume] in Urine by Automated count
346
2494
2.30
15.83
7.2
3.7
e6/l
657.5
439.0
0.14
11
29
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
53
158
3.64
15.40
2.2
1.5
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
12
12.86
15.20
2.1
2.5
umol/l
13.2
13.0
0.03
15
12
(3037467) Urinalysis macro (dipstick) panel - Urine
357
2633
2.29
15.06
6.2
3.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
230
1440
2.12
14.72
2.7
2.2
nmol/l
65.1
73.7
4.99
218
1299
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
117
557
2.44
14.58
3.6
2.5
e6/l
1.1
0.9
0.14
69
310
(3013707) Erythrocyte sedimentation rate by Westergren method
366
2745
2.29
14.55
5.1
3.5
mm/h
11.0
9.6
1.12
347
2541
(3042936) Bacteria identified in Isolate by Culture
100
457
2.49
13.54
2.5
1.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
38
98
4.12
13.51
1.1
1.3
titre
43.3
55.7
—
6
7
(3021589) Normoblasts [#/volume] in Blood
255
1700
2.04
13.37
15.0
7.9
e9/l
0.0
0.0
1.29
212
1394
(3009261) Glucose [Presence] in Urine by Test strip
277
1905
2.04
13.28
4.8
3.2
estimate
0.0
0.0
0.00
56
338
(3021601) Nitrite [Presence] in Urine by Test strip
274
1887
2.02
12.98
6.2
4.3
estimate
0.0
0.0
0.00
55
347
(3035350) Ketones [Presence] in Urine by Test strip
274
1887
2.02
12.98
4.7
3.1
estimate
0.0
0.0
0.00
52
349
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
127
657
2.26
12.93
3.9
2.6
ng/l
1055.9
962.7
0.14
111
523
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
60
216
3.02
12.85
1.7
1.5
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
28
59
4.97
12.75
2.6
5.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
120
611
2.27
12.66
2.2
1.5
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
25
48
5.43
12.61
4.2
2.5
%
17.6
16.3
0.90
17
27
(3027945) Reticulocytes/100 erythrocytes in Blood
77
326
2.61
12.15
3.2
2.7
%
1.7
1.7
0.07
70
294
(3012501) Base excess in Blood by calculation
26
54
5.03
12.04
6.0
2.8
mmol/l
2.4
2.7
0.13
17
36
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
76
323
2.60
11.90
3.4
2.3
u/l
3751.6
4805.4
0.11
18
141
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
35
94
3.93
11.78
2.4
2.2
ug/l
905.8
323.6
0.42
35
87
(3019550) Sodium [Moles/volume] in Serum or Plasma
448
3818
2.90
11.23
32.4
10.8
mmol/l
139.2
139.6
2.26
442
3697
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
139
784
2.08
11.17
3.0
1.8
mg/l
1.9
1.0
0.56
110
575
(1616796) Gas panel - Central venous blood
26
58
4.68
11.08
3.5
2.5
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
448
3826
2.87
11.03
32.2
10.9
mmol/l
3.9
3.9
0.12
441
3693
(3011397) Hemoglobin [Presence] in Urine by Test strip
149
871
2.02
10.80
4.0
3.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
24
52
4.80
10.58
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
24
52
4.80
10.58
1.5
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
20
37
5.59
10.48
5.3
1.9
mmol/l
1.8
1.7
0.22
20
37
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
32
88
3.82
10.42
1.3
1.3
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
14
6
23.95
10.29
4.1
1.0
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
424
3578
2.32
9.84
7.3
4.4
mu/l
1.8
2.1
0.47
409
3314
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
59
243
2.62
9.79
2.5
1.7
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
83
3.78
9.69
2.1
1.7
e6/l
1.7
15.0
0.82
23
61
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
30
83
3.78
9.69
2.2
1.8
e6/l
187.2
128.8
0.12
24
64
(3029937) Albumin [Presence] in Urine by Test strip
159
988
1.90
9.45
5.3
3.5
estimate
0.0
0.0
0.50
53
337
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
69
312
2.41
9.41
2.9
4.0
u/l
224.4
240.5
0.49
64
295
(3013512) EKG study
136
805
1.95
9.33
6.4
3.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
55
225
2.63
9.25
3.0
2.6
e9/l
67.1
69.1
0.14
44
164
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
25
64
4.06
8.98
4.4
4.2
u/ml
0.3
0.3
0.03
12
35
(3022313) Gas panel - Capillary blood
42
154
2.89
8.69
4.2
4.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
11
13
8.63
8.49
2.2
8.3
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
22
54
4.22
8.34
4.4
1.8
iu/ml
166.6
826.0
—
5
5
(3021879) Hepatitis B virus core Ab [Presence] in Serum
76
378
2.19
8.28
1.4
1.5
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
49
201
2.60
8.19
3.6
3.3
ng/l
83.1
65.0
0.77
44
177
(3006653) Thiamine [Moles/volume] in Blood
10
11
9.26
8.11
1.5
1.5
nmol/l
162.3
146.4
—
10
11
(3044640) Blood type and Crossmatch panel - Blood
171
1131
1.78
8.09
3.0
2.0
—
—
—
0
0
(3020891) Body temperature
32
105
3.19
8.01
8.1
4.0
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
415
3554
2.06
7.98
5.8
3.6
mmol/l
6.2
5.7
4.20
396
3262
(3008295) Osmolality of Serum or Plasma
16
31
5.30
7.98
1.6
1.2
mosm/kgh2o
293.2
287.3
0.30
11
24
(46235355) HIV 1 and 2 tests - Meaningful Use set
184
1248
1.76
7.96
2.4
2.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
566
0.24
7.92
1.4
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
61
289
2.27
7.45
2.2
2.2
g/l
10.2
10.2
0.03
55
266
(3000494) Fungus identified in Specimen by Culture
75
388
2.10
7.37
1.7
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
130
823
1.79
6.98
4.5
3.9
mg/mmol
7.1
11.0
0.50
83
533
(3022217) INR in Platelet poor plasma by Coagulation assay
65
325
2.15
6.96
11.8
16.6
inr
1.0
1.2
—
10
47
(3017181) Myelocytes/100 leukocytes in Blood
55
257
2.28
6.94
5.2
4.7
%
1.4
0.7
0.79
16
80
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
380
3227
1.77
6.62
6.6
4.5
mmol/mol
40.4
38.2
2.79
357
3031
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
233
1755
1.62
6.41
6.2
3.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
51
240
2.25
6.33
1.5
1.6
g/l
1.3
1.5
0.32
45
219
(44790049)
15
34
4.52
6.27
2.0
1.4
—
—
—
0
0
(44790048)
15
34
4.52
6.27
2.0
1.4
—
—
—
0
0
(44790047)
15
34
4.52
6.27
2.0
1.4
—
—
—
0
0
(44806118)
15
34
4.52
6.27
2.0
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
200
1462
1.62
6.15
5.3
3.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
441
3953
2.10
6.12
29.4
10.1
mg/l
21.3
21.9
0.15
392
2995
(3012516) Albumin [Mass/volume] in Urine
121
778
1.74
6.07
3.7
3.2
mg/l
615.6
332.2
0.20
76
509
(3030905) Polymorphonuclear cells [#/volume] in Blood
22
68
3.34
6.07
2.3
3.3
e9/l
3.8
4.1
0.31
22
68
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
9
341
0.25
5.98
1.2
1.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
69
3.29
5.94
2.5
3.6
%
56.1
56.3
0.02
22
69
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
153
1054
1.65
5.92
1.5
1.3
u/ml
1.1
1.4
0.17
35
266
(3052851) Hemolysis interference index of Serum or Plasma
25
86
3.01
5.81
3.2
2.6
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
50
242
2.19
5.81
5.5
4.9
%
0.2
0.1
0.23
14
73
(3036489) Thrombin time
36
151
2.49
5.78
5.3
2.6
s
20.5
21.0
0.32
31
132
(3001122) Ferritin [Mass/volume] in Serum or Plasma
242
1881
1.56
5.57
3.7
2.6
ug/l
94.9
85.9
0.42
228
1747
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
13
29
4.58
5.54
1.1
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
13
29
4.58
5.54
5.8
1.8
%
91.0
91.0
0.01
13
29
(3002179) Metamyelocytes/100 leukocytes in Blood
48
235
2.16
5.43
4.1
4.6
%
0.7
0.3
0.57
12
56
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
134
910
1.65
5.42
2.4
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
137
941
1.63
5.28
1.6
1.4
g/l
2.3
2.3
0.02
82
569
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
26
97
2.77
5.26
2.0
1.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
144
1004
1.61
5.22
2.6
2.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
22
75
3.02
5.21
2.4
1.8
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
82
491
1.80
5.21
2.5
1.8
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
36
160
2.35
5.12
1.3
1.3
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
8
6
13.52
5.09
1.3
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
9
9
10.16
5.04
2.1
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
87
538
1.75
4.95
3.4
2.5
mmol/l
2.4
2.4
0.04
73
463
(3048689) Calprotectin [Mass/mass] in Stool
93
589
1.71
4.86
2.1
2.5
ug/g
69.6
111.6
1.90
76
458
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
450
4128
2.03
4.85
18.6
8.2
u/l
28.7
26.3
1.54
440
3984
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
23
84
2.82
4.84
1.3
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
14
37
3.87
4.84
1.1
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
16
448
0.34
4.84
1.1
1.6
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
46
232
2.08
4.83
5.8
5.0
%
0.0
0.0
0.49
11
64
(3020630) Protein [Mass/volume] in Serum or Plasma
41
198
2.17
4.81
2.0
2.4
g/l
65.1
67.2
0.70
36
182
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
10
9.14
4.80
2.6
4.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
10
9.14
4.80
2.6
4.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
128
886
1.60
4.73
1.7
1.6
mmol/l
1.7
1.4
2.76
107
768
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
59
330
1.89
4.64
1.2
1.2
iu/ml
63.7
168.1
2.74
18
120
(3002385) Erythrocyte distribution width [Ratio]
393
3481
1.64
4.60
35.5
12.6
%
13.7
13.4
3.72
387
3416
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
14
40
3.57
4.36
1.1
1.1
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
10
22
4.62
4.32
1.5
2.4
ug/l
30.8
20.4
—
10
22
(3023419) Bacteria identified in Sputum by Culture
12
31
3.94
4.28
3.0
2.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
14
41
3.49
4.21
1.4
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
93
612
1.64
4.18
2.7
1.9
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
13
7.03
4.18
1.9
8.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
20
74
2.77
4.13
3.5
2.3
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
391
3491
1.58
4.08
23.3
9.2
ml/min/173m2
93.5
91.0
1.12
321
2743
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
58
3.00
4.05
2.3
2.1
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
410
3711
1.62
3.94
5.1
3.9
mmol/l
2.7
2.8
2.45
385
3445
(3041096) Erythrocytes [Presence] in Urine by Automated
147
1088
1.50
3.94
4.7
2.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
83
539
1.65
3.92
1.3
1.4
titre
297.1
439.6
0.71
14
102
(4306422)
19
71
2.74
3.87
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
390
3494
1.56
3.87
4.4
3.3
mmol/l
1.5
1.2
6.07
365
3244
(3000570) Elastase.pancreatic [Mass/mass] in Stool
21
84
2.57
3.76
1.6
1.3
ug/g
298.1
289.7
0.05
12
47
(3022621) pH of Urine by Test strip
40
211
1.97
3.75
4.7
2.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
128
930
1.51
3.72
6.7
4.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
135
992
1.50
3.72
2.1
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
25
111
2.32
3.61
2.1
1.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
120
867
1.51
3.57
3.1
1.9
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
6
6
10.10
3.50
3.8
3.3
mmol/l
23.9
26.4
—
6
6
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
30
146
2.12
3.49
2.4
2.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
491
0.46
3.49
1.6
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
40
218
1.91
3.43
1.2
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
70
2.63
3.42
1.9
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
18
70
2.63
3.42
1.8
1.5
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
8
14
5.79
3.35
9.4
2.0
%
125.1
123.4
—
8
14
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
401
3649
1.53
3.35
5.0
3.6
mmol/l
4.6
4.7
1.39
379
3417
(3035285) Chloride [Moles/volume] in Venous blood
11
32
3.49
3.35
2.8
2.6
mmol/l
107.8
105.6
0.54
11
32
(3041354) Potassium [Moles/volume] in Venous blood
11
32
3.49
3.35
2.8
2.6
mmol/l
3.9
4.0
0.19
11
32
(3045788) Cell count panel - Pleural fluid
9
19
4.80
3.25
1.2
1.3
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
28
3.62
3.21
1.1
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
53
323
1.72
3.18
4.7
3.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
66
429
1.62
3.11
1.2
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
50
2.85
3.11
1.6
1.4
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
44
256
1.79
3.10
1.7
1.3
u/ml
330.7
334.9
0.01
39
238
(3011648) Oxygen content in Venous blood
10
29
3.50
3.06
1.8
8.7
%
9.9
11.6
—
10
29
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
22
100
2.26
3.04
1.7
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
17
69
2.52
2.99
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
5
5
10.08
2.98
1.0
2.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
5
10.08
2.98
1.8
1.4
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
40
230
1.80
2.93
1.4
1.4
iu/l
24.0
19.0
0.44
32
188
(36660697) Celiac disease serology panel - Serum
59
379
1.63
2.92
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
107
786
1.46
2.90
3.3
2.3
umol/l
341.9
4093.8
1.94
90
697
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
13
5.44
2.88
3.7
3.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
13
5.44
2.88
3.7
3.5
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
24
116
2.12
2.88
2.0
6.0
g/l
0.1
0.3
—
10
51
(3023410) Appearance of Cerebral spinal fluid
12
41
2.97
2.87
3.6
2.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
36
3.10
2.82
1.9
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
37
3.02
2.71
1.1
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
11
37
3.02
2.71
1.6
1.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
6
10
6.06
2.70
1.0
1.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
290
0.40
2.68
1.5
1.5
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
73
2.38
2.68
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
43
2.84
2.66
1.7
1.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
10
32
3.17
2.66
2.9
2.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
10
32
3.17
2.66
3.6
3.9
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
27
141
1.97
2.66
1.1
1.7
—
10.2
—
0
6
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
7
15
4.72
2.60
1.7
2.9
umol/l
27.7
29.1
—
7
15
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
25
3.65
2.58
2.1
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
11
271
0.39
2.58
1.7
1.6
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
42
659
0.60
2.55
1.7
1.5
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
42
256
1.70
2.55
1.2
1.2
—
19.9
—
0
14
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
18
82
2.24
2.50
1.9
1.1
u/ml
110.6
97.6
—
6
14
(3017732) Neutrophils [#/volume] in Blood
42
258
1.69
2.48
2.9
2.2
e9/l
4.7
4.1
0.93
34
212
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
394
3636
1.42
2.48
4.8
3.6
mmol/l
1.4
1.5
4.83
373
3382
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
8
208
0.37
2.47
1.4
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
21
103
2.09
2.45
2.2
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
15
64
2.39
2.41
1.7
2.1
ug/min
41.0
134.2
—
10
34
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
20
97
2.11
2.40
1.8
1.2
u/ml
243.0
198.9
0.33
14
54
(3020491) Glucose [Moles/volume] in Blood
9
27
3.38
2.40
2.2
1.5
mmol/l
7.0
6.2
—
9
22
(3021788) Differential panel - Synovial fluid
11
40
2.79
2.39
2.5
1.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
8
6.30
2.37
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
8
6.30
2.37
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
9
28
3.25
2.31
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
35
2.90
2.31
1.6
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
18
85
2.16
2.31
1.8
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
11
41
2.72
2.29
1.2
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
86
2.13
2.25
1.9
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
52
347
1.56
2.23
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
16
73
2.23
2.23
1.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
25
136
1.88
2.22
1.8
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
10
36
2.81
2.21
2.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
15
67
2.28
2.19
1.0
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
444
4217
1.53
2.14
26.0
9.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
25
3.24
2.10
3.3
2.4
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
31
2.94
2.08
1.1
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
16
76
2.14
2.04
1.5
1.2
u/ml
3.6
4.4
—
7
30
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
16
76
2.14
2.04
1.5
1.2
u/ml
5.7
4.6
—
6
29
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
18
90
2.04
2.03
1.2
1.3
—
—
—
0
0
(4027681)
8
26
3.11
2.02
1.5
1.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
10
38
2.67
2.02
2.6
1.9
—
—
—
0
0
(40761535) Cells panel - Urine sediment
39
251
1.60
1.97
4.7
3.2
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
266
0.47
1.95
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
266
0.47
1.95
1.3
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
5
11
4.58
1.94
1.0
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
27
2.99
1.94
1.4
1.5
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
16
3.78
1.94
1.0
1.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
33
2.76
1.94
1.2
1.5
—
—
—
0
0
(4010399)
38
244
1.60
1.94
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
265
0.48
1.93
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
265
0.48
1.93
1.3
1.4
—
—
—
0
0
(4268621)
12
52
2.34
1.89
2.4
2.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
221
0.44
1.85
1.4
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
6
17
3.56
1.84
1.2
1.2
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
17
3.56
1.84
1.0
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
6
17
3.56
1.84
1.8
2.8
umol/l
1.7
1.9
—
6
17
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
12
4.20
1.82
1.0
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
232
0.46
1.81
1.5
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
23
3.07
1.80
1.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
218
0.45
1.79
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
27
162
1.71
1.79
1.7
1.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
10
217
0.45
1.77
1.3
1.4
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
74
2.06
1.76
1.9
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
37
242
1.57
1.76
1.4
1.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
18
3.36
1.75
1.0
1.4
—
—
—
0
0
(3019225) pH of Specimen
40
268
1.54
1.72
5.5
3.3
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
5
13
3.87
1.72
3.6
3.2
ug/l
1.6
2.9
—
5
13
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
13
3.87
1.72
1.4
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
5
13
3.87
1.72
1.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
20
112
1.82
1.67
1.4
1.6
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
19
3.18
1.66
1.5
2.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
31
2.61
1.66
1.1
1.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
7
25
2.83
1.65
1.0
1.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
19
325
0.57
1.65
1.2
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
31
198
1.60
1.64
1.5
1.3
miu/ml
283.6
277.7
—
5
106
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
5
14
3.60
1.62
1.2
3.6
u/l
179.8
205.9
—
5
14
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
14
3.60
1.62
1.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
14
3.60
1.62
1.0
1.0
miu/ml
2838.8
1085.4
—
5
14
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
14
3.60
1.62
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
10
43
2.35
1.61
1.3
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
51
366
1.44
1.59
11.0
5.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
31
201
1.58
1.55
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
33
2.45
1.54
1.3
1.3
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
33
2.45
1.54
1.3
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
33
2.45
1.54
1.1
1.3
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
5
15
3.36
1.52
2.0
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
51
2.18
1.51
1.2
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
24
147
1.67
1.50
4.5
2.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
9
38
2.39
1.46
1.0
1.5
nmol/l
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
31
205
1.55
1.44
1.8
1.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
16
88
1.85
1.43
2.0
1.8
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
46
2.20
1.40
1.7
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
17
96
1.80
1.40
1.3
1.1
u/ml
0.2
2.8
—
7
23
(3004588) Protein electrophoresis panel - Serum or Plasma
24
150
1.63
1.40
1.8
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
13
67
1.97
1.39
1.2
1.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
42
299
1.44
1.39
2.1
2.1
nmol/l
11.5
13.2
0.53
33
274
(3009214) Lutropin [Units/volume] in Serum or Plasma
27
175
1.57
1.37
1.6
1.4
u/l
5.6
7.7
1.29
21
140
(3036071) Salmonella sp Ab [Titer] in Serum
5
17
2.96
1.36
1.0
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
13
68
1.94
1.34
5.5
4.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
68
1.94
1.34
2.6
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
9
44
2.06
1.27
1.0
1.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
36
2.24
1.24
1.0
1.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
19
2.65
1.22
1.2
3.3
—
—
—
0
0
(4211845)
5
19
2.65
1.22
3.4
3.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
26
2.32
1.19
2.2
1.2
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
38
2.12
1.19
1.0
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
10
50
2.02
1.17
1.9
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
18
112
1.63
1.10
1.3
1.1
u/ml
0.3
2.0
1.11
13
54
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
32
2.20
1.08
4.1
3.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
22
145
1.54
1.08
2.1
1.6
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
33
2.14
1.06
1.1
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
33
2.14
1.06
1.1
2.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
9
46
1.97
1.04
1.0
1.0
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
20
133
1.53
0.96
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
14
85
1.67
0.95
1.6
2.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
118
0.50
0.95
1.2
1.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
19
126
1.53
0.92
1.2
1.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
78
1.68
0.92
2.6
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
36
271
1.35
0.92
1.1
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
77
643
1.23
0.91
1.3
1.2
u/ml
1.2
8.5
3.24
17
245
(3002523) Influenza virus A Ag [Presence] in Specimen
5
101
0.49
0.90
1.0
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
79
1.66
0.89
3.6
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
20
136
1.49
0.88
1.4
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
31
1.95
0.84
2.0
3.2
nmol/l
4.0
2.8
—
6
31
(3002256) Pathology report gross observation
50
401
1.27
0.84
1.3
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
12
73
1.66
0.82
3.8
4.2
mg/l
20.1
29.1
—
6
53
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
32
1.89
0.82
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
58
1.74
0.80
1.5
2.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
19
131
1.47
0.79
1.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
33
1.83
0.79
1.3
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
25
0.00
0.79
0.0
2.5
—
56.1
—
0
25
(1761868) Lipid panel - Serum or Plasma
129
1443
0.86
0.79
3.3
2.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
48
1.68
0.79
1.1
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
100
0.49
0.78
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
31
235
1.34
0.78
2.2
2.2
ml/min/173m2
81.0
76.7
0.12
13
84
(4024509)
0
27
0.00
0.77
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
160
0.62
0.75
1.6
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
9
55
1.65
0.74
1.0
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
26
1.93
0.71
1.4
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
5
26
1.93
0.71
1.2
2.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
26
1.93
0.71
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
26
1.93
0.71
1.2
1.8
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
41
1.72
0.70
1.1
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
42
1.68
0.68
1.3
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
5
27
1.86
0.68
2.0
1.3
e6/l
12204.0
28729.7
—
5
16
(3044941) Cell count panel - Synovial fluid
7
44
1.60
0.65
2.6
1.3
—
—
—
0
0
(44813793)
5
29
1.73
0.64
1.4
1.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
77
669
1.18
0.63
1.4
1.2
iu/ml
11.5
32.5
4.15
17
195
(3032773) Endomysium IgG Ab [Titer] in Serum
8
49
1.64
0.62
1.3
1.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
51
1.58
0.60
2.4
2.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
35
1.72
0.58
1.2
1.5
pg
31.8
33.0
—
6
35
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
27
212
1.29
0.57
2.3
1.8
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
6
37
1.63
0.55
1.2
1.2
pmol/l
286.7
380.9
—
6
30
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
45
533
0.83
0.55
2.0
2.6
ug/l
0.8
0.7
0.26
37
312
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
63
1.44
0.52
1.0
1.0
—
—
—
0
0
(3000492) Spirometry study
45
380
1.20
0.52
1.9
1.4
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
9
64
1.41
0.51
1.1
2.0
g/l
0.7
0.8
—
9
54
(3010813) Leukocytes [#/volume] in Blood
459
4521
1.22
0.50
42.3
15.2
e9/l
7.2
6.7
5.21
452
4402
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
10
144
0.69
0.50
1.7
1.5
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
45
1.56
0.49
1.6
1.2
u/l
15.7
11.1
—
7
39
(40760888) Immunoglobulin light chains.free panel - Serum
7
46
1.53
0.48
2.7
4.7
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
458
4514
1.21
0.46
42.4
15.1
e9/l
260.7
257.2
0.56
451
4409
(4094501)
11
77
1.44
0.46
1.2
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
77
1.44
0.46
1.8
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
121
1.33
0.44
1.3
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
51
1.38
0.44
1.4
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
458
4517
1.20
0.43
42.2
15.1
fl
90.2
89.9
0.72
452
4459
(3035941) MCH [Entitic mass]
458
4517
1.20
0.43
42.2
15.0
pg
30.1
30.1
0.17
452
4458
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
122
1.32
0.43
1.1
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
458
4518
1.19
0.42
42.3
15.1
e12/l
4.5
4.6
4.94
450
4403
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
32
1.57
0.42
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
33
1.52
0.41
1.2
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4034850)
16
123
1.31
0.41
11.6
9.6
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
458
4520
1.19
0.40
42.7
15.2
g/l
133.4
136.7
4.80
453
4463
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
17
0.00
0.40
0.0
1.2
—
298.8
—
0
10
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
35
1.43
0.39
1.2
1.5
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
63
702
0.88
0.39
3.0
3.7
%
22.1
21.6
0.10
24
293
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
37
1.35
0.37
1.2
1.1
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
17
135
1.27
0.35
1.4
1.6
g/l
1.3
1.2
0.99
17
129
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
43
1.40
0.35
1.2
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
14
178
0.78
0.35
1.3
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
34
293
1.17
0.34
1.4
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
45
1.34
0.34
2.2
1.3
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
94
869
1.10
0.34
3.4
4.0
ug/l
1.2
1.9
3.17
83
770
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
128
1.26
0.32
1.3
2.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
16
131
1.23
0.27
1.4
1.6
g/l
0.2
0.2
0.14
16
125
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
65
1.23
0.27
1.4
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
73
0.68
0.26
1.0
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
313
3201
0.94
0.25
4.3
3.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
87
816
1.08
0.24
2.1
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
6
85
0.70
0.24
1.2
1.2
—
36.1
—
0
9
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(4062490)
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
39
1.28
0.23
1.4
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
129
1.17
0.17
1.4
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
394
3897
1.05
0.16
30.8
11.2
%
39.5
40.5
1.87
269
3163
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
71
1.13
0.16
1.4
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
136
1319
1.04
0.14
1.5
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
12
103
1.17
0.14
1.5
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
23
252
0.91
0.13
2.2
4.5
ug/l
11.1
22.7
0.26
18
202
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
118
1143
1.04
0.13
1.7
1.7
—
—
—
0
0
(4035726)
26
239
1.09
0.12
1.5
1.3
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
36
382
0.94
0.10
4.3
3.6
%
29.9
31.8
0.43
29
251
(40768804) Tissue Pathology biopsy report
144
1412
1.03
0.08
2.3
1.9
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
8
76
1.05
0.07
1.0
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
52
501
1.04
0.07
1.5
1.9
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
12
131
0.91
0.05
1.3
1.1
—
8.0
—
0
16
(1002224) Polysomnography panel
20
191
1.05
0.03
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
81
809
1.00
0.00
1.5
1.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
7
73
0.96
0.00
1.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
35.8
—
0
5
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
81
0.99
0.00
1.0
1.1
—
2.8
—
0
5
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
62
0.97
0.00
1.0
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
55
0.91
0.00
3.8
1.9
%
12.6
13.1
—
5
55
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
6
0.00
0.00
0.0
3.2
—
0.5
—
0
6
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: Z21_PERSONAL_HISTORY_RISK__NOT_ELSEW_CLASSIFIED – Personal history of risk-factors, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).